Cleared Traditional

K070627 - OPACIDEN SOLUTION

K070627 is an FDA 510(k) clearance for OPACIDEN SOLUTION, manufactured by Ciden Technologies, LLC. The device is a Class 2 General Hospital device with product code MED cleared through the Traditional 510(k) pathway after a 149-day FDA review.

K070627 · Ciden Technologies, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2007
Decision
149d
Days
Class 2
Risk

K070627 is an FDA 510(k) clearance for the OPACIDEN SOLUTION. Classified as Sterilant, Medical Devices (product code MED), Class II - Special Controls.

Submitted by Ciden Technologies, LLC (Bellaire, US). The FDA issued a Cleared decision on August 2, 2007 after a review of 149 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6885 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Ciden Technologies, LLC devices

FDA 510(k) Submission Details - K070627

510(k) Number K070627 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2007
Decision Date August 02, 2007
Days to Decision 149 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 129d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MED Device Classification - Class 2, Special Controls

Product Code MED Sterilant, Medical Devices
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.6885
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - MED Sterilant, Medical Devices

All 31
Devices cleared under the same product code (MED) and FDA review panel - the closest regulatory comparables to K070627.
MODIFICATION TO RESERT XL HLD HIGH LEVEL DISINFECTANT
K091022 · STERIS Corporation · Apr 2010
SYSTEM 1.5 STERILE PROCESSING SYSTEM
K090036 · STERIS Corporation · Apr 2010
RESERT XL HLD HIGH LEVEL DISINFECTANT
K080420 · STERIS Corporation · Sep 2008
CIDEX OPA CONCENTRATE
K032959 · Advanced Sterilization Products · Apr 2005
0.55% ORTH-PHTHALALDEHYDE SOLUTION
K030004 · Advanced Sterilization Products · Feb 2003
CIDEX OPA SOLUTION (0.55% ORTHRO-PHTHALALDEHYDE SOLUTION)
K002401 · Advanced Sterilization Products · Aug 2000